Literature DB >> 583332

Comparative bioavailability of a microcrystalline theophylline tablet and uncoated aminophylline tablets.

L N Sansom, R W Milne, D Cooper.   

Abstract

The bioavailability of a rapidly dissolving tablet of theophylline and three brands of standard aminophylline tablets was estimated in a four way cross-over study involving 8 healthy adult volunteers. The relative extent of bioavailability as assessed by the measurement of the total area under the plasma concentration time curves showed no difference between the products (P greater than 0.05). Computed estimates of the rate of drug absorption were similar for all 4 products tested. The results indicate that the rapidly dissolving tablet offers no advantage in respect to rate and extent of absorption over conventional aminophylline tablets.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 583332     DOI: 10.1007/bf00568203

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Influence of formulation on bioavailability of theophylline.

Authors:  P G Welling; J Domoradzki; J A Sims; C E Reed
Journal:  J Clin Pharmacol       Date:  1976-01       Impact factor: 3.126

2.  Pharmacokinetics of theophylline in children with asthma.

Authors:  E F Ellis; R Koysooko; G Levy
Journal:  Pediatrics       Date:  1976-10       Impact factor: 7.124

3.  Pharmacokinetics of intravenous theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

4.  Rational intravenous doses of theophylline.

Authors:  P A Mitenko; R I Ogilvie
Journal:  N Engl J Med       Date:  1973-09-20       Impact factor: 91.245

5.  Pharmacokinetics of theophylline. Application to adjustment of the clinical dose of aminophylline.

Authors:  J W Jenne; M S Wyze; F S Rood; F M MacDonald
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

6.  Rapidly achieved plasma concentration plateaus, with observations on theophylline kinetics.

Authors:  P A Mitenko; R I Ogilvie
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

7.  A rapidly dissolving theophylline tablet.

Authors:  A Cohen; C Johnson; O Re
Journal:  Curr Ther Res Clin Exp       Date:  1975-05

8.  Absolute bioavailability of oral theophylline.

Authors:  L Hendeles; M Weinberger; L Bighley
Journal:  Am J Hosp Pharm       Date:  1977-05

9.  Theophylline bioavailability following chronic dosing of an elixir and two solid dosage forms.

Authors:  D D Shen; M Fixley; D L Azarnoff
Journal:  J Pharm Sci       Date:  1978-07       Impact factor: 3.534

10.  Theophylline bioavailability: a comparison of the oral absorption of a theophylline elixir and two combination theophylline tablets to intravenous aminophylline.

Authors:  M Fixley; D D Shen; D L Azarnoff
Journal:  Am Rev Respir Dis       Date:  1977-06
View more
  3 in total

Review 1.  A clinical and pharmacokinetic basis for the selection and use of slow release theophylline products.

Authors:  L Hendeles; R P Iafrate; M Weinberger
Journal:  Clin Pharmacokinet       Date:  1984 Mar-Apr       Impact factor: 6.447

2.  A comparison of the pharmacokinetics of theophylline in asthmatic children in the acute episode and in remission.

Authors:  J D Arnold; G N Hill; L N Sansom
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

3.  Comparative pharmacokinetics of theophylline and aminophylline in man.

Authors:  A Aslaksen; O M Bakke; T Vigander
Journal:  Br J Clin Pharmacol       Date:  1981-03       Impact factor: 4.335

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.